The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Sustained Release Excipients Market Over The Period 2026–2030?
The sustained release excipients market has experienced substantial growth in recent years. It is anticipated to increase from $1.51 billion in 2025 to $1.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. The historical expansion of this market can be attributed to several factors, including an increase in chronic disease prevalence, the growing adoption of modified release tablets, innovations in polymer chemistry, the expansion of generic drug manufacturing, and the regulatory acceptance of sustained release formulations.
The sustained release excipients market is anticipated to experience robust expansion in the coming years. It is projected to reach $2.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This growth during the projected period is attributable to several factors, including an increased demand for long-acting injectables, the expansion of biologics and specialty drugs, greater investment in drug delivery research and development, a call for patient-centric formulations, and the widening of pharmaceutical manufacturing operations in developing economies. Key trends anticipated within the forecast timeframe encompass an escalating demand for controlled drug delivery systems, the expanded application of polymers in sustained release formulations, a surge in the adoption of oral sustained release dosage forms, the advancement of microencapsulation and coacervation technologies, and an emphasis on enhancing patient compliance coupled with a reduction in dosing frequency.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp
Which Major Factors Are Driving The Expansion Of The Sustained Release Excipients Market?
The sustained-release excipients market is anticipated to expand due to the increasing need for personalized medicine. Personalized medicine, also known as personalized care, involves medical practitioners examining patients’ distinct genes, proteins, and other physiological elements to deliver and manage customized treatment through precision medicine. These excipients are vital in personalized medicine, facilitating the creation of drug formulations specifically adapted to each patient’s requirements. An example of this trend is seen in February 2024, when the Personalised Medicine Coalition, a US-based hospital and health care organization, reported that the FDA cleared 16 new personalized treatments for rare disease patients in 2023, an increase from 6 in 2022. Consequently, the rising demand for personalized medicine is fueling expansion in the sustained-release excipients market.
How Is The Sustained Release Excipients Market Divided Into Its Major Segments?
The sustained release excipients market covered in this report is segmented –
1) By Product: Gelatin, Polymers, Minerals, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation
Subsegments:
1) By Gelatin: Type A Gelatin, Type B Gelatin
2) By Polymers: Natural Polymers, Synthetic Polymers
3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients
4) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan
How Are Trends Transforming The Sustained Release Excipients Market Landscape?
Leading companies in the sustained release excipients market are concentrating on developing advanced solutions, such as multifunctional polymer platforms, to enhance drug formulation efficiency, reduce delivery time, and support controlled-release profiles. These multifunctional polymer platforms refer to excipients that enable immediate, delayed, and sustained drug release while being compatible with formulation technologies like hot melt extrusion and solubility-enhancing spray drying. For instance, in September 2024, Evonik, a Germany-based company, commenced operations of a new spray drying facility at its Darmstadt site for EUDRAGIT polymers. This facility boosts production capacity, shortens delivery times, and integrates seamlessly with existing production networks. It leverages green electricity and steam from local waste incineration to decrease CO2 emissions by over 1,000 tons annually. Operating under IPEC-GMP pharmaceutical guidelines and directly connected to the production of aqueous dispersions, the facility minimizes transportation and streamlines the supply chain. The polymers manufactured there support immediate, delayed, and sustained release formulations, thereby strengthening Evonik’s global hub for oral drug delivery solutions and reinforcing its capability to efficiently support innovative pharmaceutical development.
Who Are The Prominent Organizations Shaping The Sustained Release Excipients Market?
Major companies operating in the sustained release excipients market are BASF SE, Ashland Global Holdings Inc, Colorcon Inc, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, Roquette Freres, Shin Etsu Chemical Co Ltd, JRS Pharma GmbH Co KG, SPI Pharma Inc, Croda International Plc, Lonza Group AG, Chemische Fabrik Budenheim KG, Asahi Kasei Corporation, DuPont de Nemours Inc, Dow Chemical Company, Eastman Chemical Company, Gattefosse SAS, Balchem Corporation, Associated British Foods plc, Ransom Naturals Ltd, Cellulose Solutions Private Limited
Read the full sustained release excipients market report here:
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report
Which Region Currently Holds The Largest Share Of The Sustained Release Excipients Market?
North America was the largest region in the global sustained release excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sustained Release Excipients Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10822&type=smp
Browse Through More Reports Similar to the Global Sustained Release Excipients Market 2026, By The Business Research Company
Sustained Release Excipients Market Report 2026
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Controlled Release Drug Delivery Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model